-
Hyaluronan in the nuchal skin of chromosomally abnormal fetuses.
Bohlandt S, von Kaisenberg CS, Wewetzer K, Christ B, Nicolaides KH, Brand-Saberi B.
Hum Reprod 2000;15:1155-8. -
Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses.
von Kaisenberg CS, Brand-Saberi B, Jonat W, Nicolaides KH.
Der Gynäkologe 1999;32:193-199. -
Lymphatic vessel hypoplasia in fetuses with Turner syndrome.
von Kaisenberg CS, Nicolaides KH, Brand-Saberi B.
Hum Reprod 1999;14:823-6. -
Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta -hCG and PAPP-A at 10-14 weeks of gestation.
Tul N, Spencer K, Noble P, Chan C, Nicolaides K.
Prenat Diagn 1999;19:1035-42. -
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:231-7. -
Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery.
Souka AP, Heath V, Flint S, Sevastopoulou I, Nicolaides KH.
Obstet Gynecol 1999;94:450-4. -
Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH.
Am J Med Genet 1999;86:205-7. -
Nuchal translucency as a marker of congenital heart disease.
Perdu M, Hyett JA, Sharland G, Snijders RS, Nicolaides KH.
Contracept Fertil Sex 1999;27:I-V. -
Assessment of umbilical arterial and venous flow using color Doppler.
Lees C, Albaiges G, Deane C, Parra M, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:250-5. -
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH.
BMJ 1999;318:81-5. -
Collagen type VI gene expression in the skin of trisomy 21 fetuses.
von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH.
Obstet Gynecol 1998;91:319-23. -
Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse.
von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B.
Anat Embryol 1998;197:105-24. -
Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;11:391-400. -
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
Lancet 1998;352:343-6. -
Detection of sex chromosome abnormalities by nuchal translucency screening at 10-14 weeks.
Sebire NJ, Snijders RJ, Brown R, Southall T, Nicolaides KH.
Prenat Diagn 1998;18:581-4. -
Screening for fetal abnormalities in multiple pregnancies.
Sebire NJ, Nicolaides KH.
Baillieres Clin Obstet Gynaecol 1998;12:19-36. -
Correct estimation of parameters for ultrasound nuchal translucency screening.
Nicolaides KH, Snijders RJ, Cuckle HS.
Prenat Diagn 1998;18:519-23. -
Cervical length at 23 weeks of gestation: the value of Shirodkar suture for the short cervix.
Heath VC, Souka AP, Erasmus I, Gibb DM, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:318-22. -
Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery.
Heath VC, Southall TR, Souka AP, Elisseou A, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:312-7. -
Cervical length at 23 weeks of gestation: relation to demographic characteristics and previous obstetric history.
Heath VC, Southall TR, Souka AP, Novakov A, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:304-11.